SAM#8725
A - Research and Development
SAMDaily.us: AWARDS - October 16, 2025
- 75A50125C00008 - 98593151.00
CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A VACCINE FOR IMMEDIATE PROTECTION AGAINST EMERGING PANDEMIC STRAINS
OSIVAX Paris 8 �le-de-France 75008 FRA
- 75A50125C00008 - 98593151.00
OFFICE OF BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY BROAD AGENCY ANNOUNCEMENT (BAA)
OSIVAX Paris 8 �le-de-France 75008 FRA
- 75A50125C00017 - 339189481.00
DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA
CIDARA THERAPEUTICS INC San Diego CA 92121 USA
- 75A50125C00008 - 98593151.00
CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A VACCINE FOR IMMEDIATE PROTECTION AGAINST EMERGING PANDEMIC STRAINS
OSIVAX Paris 8 �le-de-France 75008 FRA
| This Issue's Index | Today's SAM Daily Index Page |
Created on 14-Oct-2025 by Loren Data Corp. -- info@samdaily.us